Somatropin Patent Expiration

Somatropin was first introduced by Genentech Inc in its drug Crescormon on Jan 1, 1982. Other drugs containing Somatropin are Nutropin Aq Nuspin, Asellacrin 2, Nutropin Aq Pen, Zomacton, Norditropin Flexpro, Asellacrin 10. 4 different companies have introduced drugs containing Somatropin.


Somatropin Patents

Given below is the list of patents protecting Somatropin, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Norditropin Flexpro US9132239 Dial-down mechanism for wind-up pen Feb 01, 2032 Novo Nordisk Inc
Norditropin Flexpro US9457154 Injection device with an end of dose feedback mechanism Sep 27, 2027 Novo Nordisk Inc
Norditropin Flexpro US9687611 Injection device with torsion spring and rotatable display Feb 27, 2027 Novo Nordisk Inc
Norditropin Flexpro US7686786 Dial-down mechanism for wind-up pen Aug 03, 2026 Novo Nordisk Inc
Norditropin Flexpro USRE46363 Dial-down mechanism for wind-up pen Aug 03, 2026 Novo Nordisk Inc
Norditropin Flexpro US10220155 Syringe device with a dose limiting mechanism and an additional safety mechanism Jul 17, 2026 Novo Nordisk Inc
Norditropin Flexpro US8920383 Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left Jul 17, 2026 Novo Nordisk Inc
Norditropin Flexpro US9775953 Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left Jul 17, 2026 Novo Nordisk Inc
Norditropin Flexpro US10357616 Injection device with an end of dose feedback mechanism Jan 20, 2026 Novo Nordisk Inc
Norditropin Flexpro US10376652 Automatic injection device with a top release mechanism Jan 20, 2026 Novo Nordisk Inc
Norditropin Flexpro US9108002 Automatic injection device with a top release mechanism Jan 20, 2026 Novo Nordisk Inc
Norditropin Flexpro US9616180 Automatic injection device with a top release mechanism Jan 20, 2026 Novo Nordisk Inc
Norditropin Flexpro US9861757 Injection device with an end of dose feedback mechanism Jan 20, 2026 Novo Nordisk Inc
Norditropin Flexpro US8684969 Injection device with torsion spring and rotatable display Oct 20, 2025 Novo Nordisk Inc
Norditropin Flexpro US7762994 Needle mounting system and a method for mounting a needle assembly May 23, 2024

(Expired)

Novo Nordisk Inc
Norditropin Flexpro US8579869 Needle mounting system and a method for mounting a needle assembly Jun 30, 2023

(Expired)

Novo Nordisk Inc
Norditropin Flexpro US6899699 Automatic injection device with reset feature Jan 02, 2022

(Expired)

Novo Nordisk Inc
Norditropin Flexpro US8672898 Automatic injection device with reset feature Jan 02, 2022

(Expired)

Novo Nordisk Inc
Norditropin Flexpro US9486588 Automatic injection device with reset feature Jan 02, 2022

(Expired)

Novo Nordisk Inc
Norditropin Flexpro US8841252 Pharmaceutical formulation Dec 26, 2017

(Expired)

Novo Nordisk Inc
Norditropin Flexpro US5849700 Pharmaceutical formulation Dec 15, 2015

(Expired)

Novo Nordisk Inc
Norditropin Flexpro US5849704 Pharmaceutical formulation Dec 15, 2015

(Expired)

Novo Nordisk Inc



Somatropin's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List